Colgate-Palmolive (NYSE:CL) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Colgate-Palmolive (NYSE:CL) posted its quarterly earnings results on Friday. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01, RTT News reports. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same period in the previous year, the firm posted $0.87 EPS. Colgate-Palmolive updated its FY 2025 guidance to EPS.

Colgate-Palmolive Trading Down 4.7 %

Shares of NYSE CL opened at $86.64 on Friday. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market cap of $70.78 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 3.70 and a beta of 0.44. The business’s 50 day moving average price is $91.52 and its 200-day moving average price is $97.25.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Wall Street Analyst Weigh In

CL has been the subject of a number of research reports. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Stifel Nicolaus dropped their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $102.00.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.